Welcure Drugs & Pharmaceuticals (BOM:524661) GF Score: 20/100 (As of Aug. 25, 2026) — 68% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524661 Welcure Drugs & Pharmaceuticals Ltd BOM:524661
20 GF Score
Price ₹0.22
! 5 Warning Signs
View Full Analysis

What is Welcure Drugs & Pharmaceuticals GF Score?

Welcure Drugs & Pharmaceuticals BOM:524661 20 GF Score is 20 as of Aug. 25, 2026, which is 68% below its 10-year median of 62.00. GuruFocus rates BOM:524661 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

Welcure Drugs & Pharmaceuticals has the GF Score of 20, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 2/10
2. Profitability Rank : 3/10
3. Growth Rank : 0/10
4. GF Value Rank : 2/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Welcure Drugs & Pharmaceuticals might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Welcure Drugs & Pharmaceuticals  (BOM:524661) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Welcure Drugs & Pharmaceuticals GF Score Related Terms

BOM:524661 vs MCK, COR, CAH: GF Score Comparison

For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Welcure Drugs & Pharmaceuticals GF Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's GF Score distribution charts can be found below:

* The bar in red indicates where Welcure Drugs & Pharmaceuticals's GF Score falls into.


BOM:524661
20GF Score
Welcure Drugs & Pharmaceuticals Ltd BOM:524661
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 20 mean?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a GF Score of 20 as of Aug. 25, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. This is 68% below median its historical median of 62.00. Over the past decade, Welcure Drugs & Pharmaceuticals' GF Score has ranged from 19.00 to 86.00.
Is Welcure Drugs & Pharmaceuticals' GF Score too high?
Welcure Drugs & Pharmaceuticals' current GF Score of 20 is 68% below median its 10-year median of 62.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 86.00. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' GF Score compare to MCK and COR?
Welcure Drugs & Pharmaceuticals' GF Score of 20 can be compared against companies in the Medical Distribution industry. Historically, Welcure Drugs & Pharmaceuticals' own GF Score has ranged from 19.00 to 86.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. Welcure Drugs & Pharmaceuticals's current GF Score is 20, which is 68% below median its own 10-year median of 62.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current GF Score of 20. The current GF Score is 20, which is 68% below median its 10-year median of 62.00. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current GF Score is 20 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Welcure Drugs & Pharmaceuticals Business Description

Address Laxmi Nagar, Plot No. 55, Office No. 104, First Floor, Vijay Block, Delhi East, Delhi, Delhi, IND, 110092
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
20GF Score

Get the complete analysis for BOM:524661

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.22
Price